UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a rare hereditary syndrome that increases the risk of kidney cancer.

Related Keywords

United States ,American ,Blake Wilde ,Brian Shuch ,Heather Christofk ,Alvin Carrie Meinhardt ,Megan Craig ,Kidney Cancer Program ,Kidney Cancer Research ,National Cancer Institute ,Jonsson Comprehensive Cancer Center ,Kidney Cancer Association ,American Cancer Society ,Translational Research ,Comprehensive Cancer Center ,Cancer Discovery ,Carrie Meinhardt Endowed Chair ,Krebs Cycle ,Cancer ,Gene ,Kidney ,Kidney Cancer ,Arcinoma ,Fell ,Enetic ,Muscle ,Nucleotides ,Nutrients ,Urine ,Renal Cell Carcinoma ,Research ,Skin ,Yndrome ,Humor ,Uterus ,